{"transactions":[{"id":787493,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-09T01:18:37.000Z","date":"2026-05-08","kind":"grant","planned":false,"acquired":true,"shares":1064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This restricted stock award was granted on May 8, 2026 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program and is scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders."}],"balance_after":8997,"source":{"system":"sec-edgar","filing":"0001225208-26-005053","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005053/doc4.xml","form_type":"4"}},{"id":787492,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-09T01:18:37.000Z","date":"2026-05-08","kind":"grant","planned":false,"acquired":true,"shares":3251,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 8, 2026 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program. They are scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders."}],"balance_after":7933,"source":{"system":"sec-edgar","filing":"0001225208-26-005053","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005053/doc4.xml","form_type":"4"}},{"id":1154339,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-09T23:58:46.000Z","date":"2025-05-09","kind":"grant","planned":false,"acquired":true,"shares":1154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This restricted stock award was granted on May 9, 2025 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program and is scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders."}],"balance_after":65054,"source":{"system":"sec-edgar","filing":"0001225208-25-004954","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004954/doc4.xml","form_type":"4"}},{"id":1154338,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-09T23:58:46.000Z","date":"2025-05-09","kind":"grant","planned":false,"acquired":true,"shares":3528,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 9, 2025 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program. They are scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders."}],"balance_after":63900,"source":{"system":"sec-edgar","filing":"0001225208-25-004954","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004954/doc4.xml","form_type":"4"}},{"id":1268128,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true}}],"security":"Director Stock Option (Right to Acquire)","published_at":"2025-02-14T21:41:55.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":false,"shares":5739,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":45.3167,"exercise_date":"2018-05-18","expiration_date":"2025-05-17","underlying":"Common Stock","underlying_shares":5739},"source":{"system":"sec-edgar","filing":"0001225208-25-001751","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825001751/doc4.xml","form_type":"4"}},{"id":1268127,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-02-14T21:41:55.000Z","date":"2025-02-14","kind":"sale","planned":false,"acquired":false,"shares":5739,"price":76.4202,"value":438575.5278,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $76.400 to $76.435. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":60372,"source":{"system":"sec-edgar","filing":"0001225208-25-001751","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825001751/doc4.xml","form_type":"4"}},{"id":1268126,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-02-14T21:41:55.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":true,"shares":5739,"price":45.3167,"value":260072.5413,"ownership":{"direct":true},"balance_after":66111,"source":{"system":"sec-edgar","filing":"0001225208-25-001751","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825001751/doc4.xml","form_type":"4"}},{"id":1522419,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-09T23:43:48.000Z","date":"2024-05-08","kind":"grant","planned":false,"acquired":true,"shares":999,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This restricted stock award was granted on May 8, 2024 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program and is scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders."}],"balance_after":60372,"source":{"system":"sec-edgar","filing":"0001225208-24-005898","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005898/doc4.xml","form_type":"4"}},{"id":1522418,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-09T23:43:48.000Z","date":"2024-05-08","kind":"grant","planned":false,"acquired":true,"shares":3055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 8, 2024 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program. They are scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders."}],"balance_after":59373,"source":{"system":"sec-edgar","filing":"0001225208-24-005898","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005898/doc4.xml","form_type":"4"}},{"id":1882349,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-22T22:09:12.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":1580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2024 Annual Meeting of Shareholders. The Reporting Person has elected to defer the settlement of the RSU Award until Separation from Service"}],"balance_after":13818,"source":{"system":"sec-edgar","filing":"0001562180-23-004395","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000156218023004395/primarydocument.xml","form_type":"4"}},{"id":1894016,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-15T22:23:34.000Z","date":"2023-05-12","kind":"grant","planned":false,"acquired":true,"shares":898,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This restricted stock was granted on May 12, 2023 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program and is scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders."}],"balance_after":56318,"source":{"system":"sec-edgar","filing":"0001225208-23-005908","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005908/doc4.xml","form_type":"4"}},{"id":1894015,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-15T22:23:34.000Z","date":"2023-05-12","kind":"grant","planned":false,"acquired":true,"shares":2803,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 12, 2023 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program. They are scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders."}],"balance_after":55420,"source":{"system":"sec-edgar","filing":"0001225208-23-005908","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005908/doc4.xml","form_type":"4"}},{"id":2269981,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-16T22:45:47.000Z","date":"2022-05-12","kind":"grant","acquired":true,"shares":1812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the award of restricted stock units. The Reporting Person elected to defer the vesting of the RSU Award until Separation from Service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes RSUs which the reporting person elected to defer the vesting of the award until Separation from Service."}],"balance_after":12238,"source":{"system":"sec-edgar","filing":"0001209191-22-029334","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919122029334/doc4.xml","form_type":"4"}},{"id":2281179,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-05T21:54:24.000Z","date":"2022-05-04","kind":"grant","acquired":true,"shares":737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This restricted stock was granted on May 4, 2022 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program and is scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders."}],"balance_after":52617,"source":{"system":"sec-edgar","filing":"0001225208-22-006590","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006590/doc4.xml","form_type":"4"}},{"id":2281178,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-05T21:54:24.000Z","date":"2022-05-04","kind":"grant","acquired":true,"shares":2300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 4, 2022 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program. They are scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders."}],"balance_after":51880,"source":{"system":"sec-edgar","filing":"0001225208-22-006590","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006590/doc4.xml","form_type":"4"}},{"id":2409946,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-07T21:08:42.000Z","date":"2021-12-14","kind":"gift","acquired":false,"shares":12491,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Steven R Loranger Revocable Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 14, 2021, 12,491 shares of Xylem Inc. common stock were transferred from the Steven R Loranger Revocable Trust to the Steve and Betsy Loranger Foundation."}],"balance_after":46407,"source":{"system":"sec-edgar","filing":"0001209191-22-007423","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919122007423/doc5.xml","form_type":"5"}},{"id":2714201,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-13T20:36:10.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":1328,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the award of restricted stock units. The Reporting Person elected to defer the vesting event until separation of service."}],"balance_after":22293,"source":{"system":"sec-edgar","filing":"0001209191-21-032357","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919121032357/doc4.xml","form_type":"4"}},{"id":2723743,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true}}],"security":"Director Stock Option (Right to Acquire)","published_at":"2021-05-07T22:31:10.000Z","date":"2021-05-05","kind":"grant","acquired":true,"shares":3270,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 5, 2021 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program and became fully exercisable on the grant date."}],"balance_after":3270,"derivative":{"exercise_price":91.77,"exercise_date":"2021-05-05","expiration_date":"2028-05-04","underlying":"Common Stock","underlying_shares":3270},"source":{"system":"sec-edgar","filing":"0001225208-21-007756","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821007756/doc4.xml","form_type":"4"}},{"id":2723742,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-07T22:31:10.000Z","date":"2021-05-05","kind":"grant","acquired":true,"shares":2615,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 5, 2021 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program. They are scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders. The underlying common stock (net of any shares sold to cover applicable taxes) must be held until the director ceases to serve on the Issuer's Board."}],"balance_after":49580,"source":{"system":"sec-edgar","filing":"0001225208-21-007756","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821007756/doc4.xml","form_type":"4"}},{"id":2888383,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-01T15:59:27.000Z","date":"2020-11-18","kind":"gift","acquired":false,"shares":13545,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Steven R Loranger Revokable Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 18, 2020, 13,545 shares of Xylem Inc. common stock were transferred from the Steven R Loranger Revocable Trust to the Steve and Betsy Loranger Foundation."}],"balance_after":58898,"source":{"system":"sec-edgar","filing":"0001209191-21-006383","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919121006383/doc5.xml","form_type":"5"}},{"id":2978264,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true}}],"security":"Director Stock Option (Right to Acquire)","published_at":"2020-11-17T23:50:00.000Z","date":"2020-11-16","kind":"exercise","acquired":false,"shares":19797,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":35.1967,"exercise_date":"2017-05-12","expiration_date":"2023-05-11","underlying":"Common Stock","underlying_shares":19797},"source":{"system":"sec-edgar","filing":"0001225208-20-013614","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820013614/doc4.xml","form_type":"4"}},{"id":2978263,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-11-17T23:50:00.000Z","date":"2020-11-16","kind":"exercise","acquired":true,"shares":19797,"price":35.1967,"value":696789.0699,"ownership":{"direct":true},"balance_after":46965,"source":{"system":"sec-edgar","filing":"0001225208-20-013614","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820013614/doc4.xml","form_type":"4"}},{"id":3031161,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-15T20:02:44.000Z","date":"2020-09-11","kind":"sale","acquired":false,"shares":18388,"price":83.9473,"value":1543622.9524,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price represents the weighted average price per Share of the Issuer. Shares were sold at a prices ranging from $83.42 to $84.17. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price."}],"balance_after":9098,"source":{"system":"sec-edgar","filing":"0001209191-20-050449","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919120050449/doc4.xml","form_type":"4"}},{"id":3148637,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-14T19:11:35.000Z","date":"2020-05-13","kind":"grant","acquired":true,"shares":2577,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the award of restricted stock units. The Reporting Person elected to defer the vesting event until separation of service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the transfer of 6,088 shares from the reporting person's company savings plan."}],"balance_after":20965,"source":{"system":"sec-edgar","filing":"0001209191-20-029103","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919120029103/doc4.xml","form_type":"4"}},{"id":3155047,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true}}],"security":"Director Stock Option (Right to Acquire)","published_at":"2020-05-11T18:14:02.000Z","date":"2020-05-08","kind":"grant","acquired":true,"shares":1378,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These options were granted on May 8, 2020 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program and became fully exercisable on the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 8, 2020 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program and became fully exercisable on the grant date."}],"balance_after":1378,"derivative":{"exercise_price":217.84,"exercise_date":"2020-05-08","expiration_date":"2027-05-07","underlying":"Common Stock","underlying_shares":1378},"source":{"system":"sec-edgar","filing":"0001225208-20-007367","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820007367/doc4.xml","form_type":"4"}},{"id":3155046,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-05-11T18:14:02.000Z","date":"2020-05-08","kind":"grant","acquired":true,"shares":1101,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 8, 2020 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program. They are scheduled to become 100% vested after the earlier of one year from the grant date or Issuer's next annual meeting of stockholders. The underlying common stock (net of any shares sold to cover applicable taxes) must be held until the director ceases to serve on Issuer's Board."}],"balance_after":9056,"source":{"system":"sec-edgar","filing":"0001225208-20-007367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820007367/doc4.xml","form_type":"4"}},{"id":3270313,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-14T19:50:41.000Z","date":"2020-02-12","kind":"sale","acquired":false,"shares":30000,"price":88.6126,"value":2658378.0,"ownership":{"direct":false,"nature":"By Steven R. Loranger Revocable Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"30,000 shares were sold from the Steven R. Loranger Revocable Trust."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the approximate weighted average price per share of common stock (each a \"Share\") of Xylem Inc. (the \"Issuer\"), of sales that were executed at prices ranging from $88.36 to $88.7150.  The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":72443,"source":{"system":"sec-edgar","filing":"0001209191-20-009556","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919120009556/doc4.xml","form_type":"4"}},{"id":3273617,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-13T20:58:24.000Z","date":"2019-11-14","kind":"gift","acquired":false,"shares":18475,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Steven R. Loranger Revocable Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 14, 2019, 18,475 shares of Xylem Inc. common stock were transferred from the Steven R Loranger Revocable Trust to the Steve and Betsy Loranger Foundation."}],"balance_after":102443,"source":{"system":"sec-edgar","filing":"0001209191-20-009155","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919120009155/doc5.xml","form_type":"5"}},{"id":3520417,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-17T19:52:47.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":1831,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the  award of restricted stock units.  The Reporting Person elected to defer the vesting event until separation of service."}],"balance_after":24909,"source":{"system":"sec-edgar","filing":"0001209191-19-030835","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919119030835/doc4.xml","form_type":"4"}},{"id":3530309,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-05-13T22:35:26.000Z","date":"2019-05-09","kind":"grant","acquired":true,"shares":414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This restricted stock was granted on May 9, 2019 under the Edwards Lifesciences Corporation Nonemployee Directors Stock Incentive Program and is scheduled to become 100% vested on March 15, 2020."}],"balance_after":7955,"source":{"system":"sec-edgar","filing":"0001225208-19-007859","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520819007859/doc4.xml","form_type":"4"}},{"id":3530308,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-05-13T22:35:26.000Z","date":"2019-05-09","kind":"grant","acquired":true,"shares":1323,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 9, 2019 under the Edwards Lifesciences Corporation Nonemployee Directors Stock Incentive Program.  They are scheduled to become 100% vested after the earlier of one year from the grant date or Issuer's next annual meeting of stockholders.  The underlying common stock (net of any shares sold to cover applicable taxes) must be held until the director ceases to serve on Issuer's Board."}],"balance_after":7541,"source":{"system":"sec-edgar","filing":"0001225208-19-007859","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520819007859/doc4.xml","form_type":"4"}},{"id":3590219,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-18T20:19:06.000Z","date":"2019-03-15","kind":"sale","acquired":false,"shares":10000,"price":76.9917,"value":769917.0,"ownership":{"direct":false,"nature":"By Steven R. Loranger Revocable Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"10,000 shares were sold from the Steven R. Loranger Revocable Trust."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the approximate weighted average price per share of common stock (each a \"Share\") of Xylem Inc. (the \"Issuer\"), of sales that were executed at prices ranging from $76.81 to $77.1350.  The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":120918,"source":{"system":"sec-edgar","filing":"0001209191-19-019991","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919119019991/doc4.xml","form_type":"4"}},{"id":3922570,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true}}],"security":"Director Stock Option (Right to Acquire)","published_at":"2018-05-22T23:40:12.000Z","date":"2018-05-18","kind":"grant","acquired":true,"shares":1913,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These options were granted on May 18, 2018 under the Edwards Lifesciences Corporation Nonemployee Directors Stock Incentive Program and became fully exercisable on the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 18, 2018 under the Edwards Lifesciences Corporation Nonemployee Directors Stock Incentive Program and became fully exercisable on the grant date."}],"balance_after":1913,"derivative":{"exercise_price":135.95,"exercise_date":"2018-05-18","expiration_date":"2025-05-17","underlying":"Common Stock","underlying_shares":1913},"source":{"system":"sec-edgar","filing":"0001225208-18-009754","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520818009754/doc4.xml","form_type":"4"}},{"id":3922569,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-05-22T23:40:12.000Z","date":"2018-05-18","kind":"grant","acquired":true,"shares":1655,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 18, 2018 under the Edwards Lifesciences Corporation Nonemployee Directors Stock Incentive Program.  They are scheduled to become vested 100% after the earlier of one year from the grant date or Issuer's next annual meeting of stockholders. The underlying common stock (net of any shares sold to cover applicable taxes) must be held until the reporting person ceases to serve on Issuer's Board."}],"balance_after":6218,"source":{"system":"sec-edgar","filing":"0001225208-18-009754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520818009754/doc4.xml","form_type":"4"}},{"id":3938612,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-10T16:48:04.000Z","date":"2018-05-09","kind":"grant","acquired":true,"shares":1947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2019 annual shareholders' meeting."}],"balance_after":23078,"source":{"system":"sec-edgar","filing":"0001209191-18-029118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919118029118/doc4.xml","form_type":"4"}},{"id":4124838,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-21T01:27:56.000Z","date":"2017-12-20","kind":"exercise","acquired":false,"shares":12120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":32.38,"expiration_date":"2018-10-31","underlying":"Common Stock","underlying_shares":12120},"source":{"system":"sec-edgar","filing":"0001209191-17-066695","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919117066695/doc4.xml","form_type":"4"}},{"id":4124837,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-21T01:27:56.000Z","date":"2017-12-19","kind":"exercise","acquired":false,"shares":5019,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested and exercisable."}],"balance_after":12120,"derivative":{"exercise_price":32.38,"expiration_date":"2018-10-31","underlying":"Common Stock","underlying_shares":5019},"source":{"system":"sec-edgar","filing":"0001209191-17-066695","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919117066695/doc4.xml","form_type":"4"}},{"id":4124836,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-21T01:27:56.000Z","date":"2017-12-20","kind":"sale","acquired":false,"shares":12120,"price":68.1386,"value":825839.832,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price represents the approximate weighted average price per share of common stock (each, a \"Share\") of Xylem Inc. (the \"Issuer\"), of sales that were executed at prices ranging from $68.00 to $68.34 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price."}],"balance_after":21131,"source":{"system":"sec-edgar","filing":"0001209191-17-066695","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919117066695/doc4.xml","form_type":"4"}},{"id":4124835,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-21T01:27:56.000Z","date":"2017-12-20","kind":"exercise","acquired":true,"shares":12120,"price":32.38,"value":392445.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exercise and sale were made pursuant to a 10b5-1 plan adopted by the reporting person on November 10, 2017."}],"balance_after":33251,"source":{"system":"sec-edgar","filing":"0001209191-17-066695","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919117066695/doc4.xml","form_type":"4"}},{"id":4124834,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-21T01:27:56.000Z","date":"2017-12-19","kind":"sale","acquired":false,"shares":5019,"price":68.0044,"value":341314.0836,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the approximate weighted average price per share of common stock (each, a \"Share\") of Xylem Inc. (the \"Issuer\"), of sales that were executed at prices ranging from $68.00 to $68.02 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price."}],"balance_after":21131,"source":{"system":"sec-edgar","filing":"0001209191-17-066695","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919117066695/doc4.xml","form_type":"4"}},{"id":4124833,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-21T01:27:56.000Z","date":"2017-12-19","kind":"exercise","acquired":true,"shares":5019,"price":32.38,"value":162515.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exercise and sale were made pursuant to a 10b5-1 plan adopted by the reporting person on November 10, 2017."}],"balance_after":26150,"source":{"system":"sec-edgar","filing":"0001209191-17-066695","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919117066695/doc4.xml","form_type":"4"}},{"id":4126080,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-19T18:58:00.000Z","date":"2017-12-18","kind":"exercise","acquired":false,"shares":47712,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are fully vested and exercisable."}],"balance_after":17139,"derivative":{"exercise_price":32.38,"expiration_date":"2018-10-31","underlying":"Common Stock","underlying_shares":47712},"source":{"system":"sec-edgar","filing":"0001209191-17-066272","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919117066272/doc4.xml","form_type":"4"}},{"id":4126079,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-19T18:58:00.000Z","date":"2017-12-18","kind":"sale","acquired":false,"shares":47712,"price":68.0952,"value":3248958.1824,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the approximate weighted average price per share of common stock (each, a \"Share\") of Xylem Inc. (the \"Issuer\"), of sales that were executed at prices ranging from $68.00 to $68.35 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price."}],"balance_after":21131,"source":{"system":"sec-edgar","filing":"0001209191-17-066272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919117066272/doc4.xml","form_type":"4"}},{"id":4126078,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-19T18:58:00.000Z","date":"2017-12-18","kind":"exercise","acquired":true,"shares":47712,"price":32.38,"value":1544914.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exercise and sale were made pursuant to a 10b5-1 plan adopted by the reporting person on November 10, 2017."}],"balance_after":68843,"source":{"system":"sec-edgar","filing":"0001209191-17-066272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919117066272/doc4.xml","form_type":"4"}},{"id":4130115,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-15T15:45:22.000Z","date":"2017-12-13","kind":"exercise","acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested and exercisable."}],"balance_after":64851,"derivative":{"exercise_price":32.38,"expiration_date":"2018-10-31","underlying":"Common Stock","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0001209191-17-065805","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919117065805/doc4.xml","form_type":"4"}},{"id":4130114,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-15T15:45:22.000Z","date":"2017-12-13","kind":"sale","acquired":false,"shares":200,"price":68.02,"value":13604.0,"ownership":{"direct":true},"balance_after":21131,"source":{"system":"sec-edgar","filing":"0001209191-17-065805","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919117065805/doc4.xml","form_type":"4"}},{"id":4130113,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-15T15:45:22.000Z","date":"2017-12-13","kind":"exercise","acquired":true,"shares":200,"price":32.38,"value":6476.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exercise and sale were made pursuant to a 10b5-1 plan adopted by the reporting person on November 10, 2017."}],"balance_after":21331,"source":{"system":"sec-edgar","filing":"0001209191-17-065805","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919117065805/doc4.xml","form_type":"4"}},{"id":4133129,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-13T22:49:52.000Z","date":"2017-12-11","kind":"exercise","acquired":false,"shares":196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are fully vested and exercisable."}],"balance_after":65051,"derivative":{"exercise_price":32.38,"expiration_date":"2018-10-31","underlying":"Common Stock","underlying_shares":196},"source":{"system":"sec-edgar","filing":"0001209191-17-065495","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919117065495/doc4.xml","form_type":"4"}},{"id":4133128,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-13T22:49:52.000Z","date":"2017-12-11","kind":"sale","acquired":false,"shares":196,"price":68.23,"value":13373.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the approximate weighted average price per share of common stock (each, a \"Share\") of Xylem Inc. (the \"Issuer\"), of sales that were executed at prices ranging from $68.07 to $68.39 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price."}],"balance_after":21131,"source":{"system":"sec-edgar","filing":"0001209191-17-065495","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919117065495/doc4.xml","form_type":"4"}},{"id":4133127,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-13T22:49:52.000Z","date":"2017-12-11","kind":"exercise","acquired":true,"shares":196,"price":32.38,"value":6346.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exercise and sale were made pursuant to a 10b5-1 plan adopted by the reporting person on November 10, 2017."}],"balance_after":21327,"source":{"system":"sec-edgar","filing":"0001209191-17-065495","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919117065495/doc4.xml","form_type":"4"}},{"id":4168783,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-11-08T20:15:32.000Z","date":"2017-11-06","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested and exercisable."}],"balance_after":65247,"derivative":{"exercise_price":32.38,"expiration_date":"2018-10-31","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-17-059710","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919117059710/doc4.xml","form_type":"4"}},{"id":4168782,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-08T20:15:32.000Z","date":"2017-11-06","kind":"sale","acquired":false,"shares":37700,"price":66.25,"value":2497625.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price represents the approximate weighted average price per share of common stock (each, a \"Share\") of Xylem Inc. (the \"Issuer\"), of sales that were executed at prices ranging from $66.0 to $66.7 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price."}],"balance_after":21131,"source":{"system":"sec-edgar","filing":"0001209191-17-059710","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919117059710/doc4.xml","form_type":"4"}},{"id":4168781,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-08T20:15:32.000Z","date":"2017-11-06","kind":"exercise","acquired":true,"shares":50000,"price":32.38,"value":1619000.0,"ownership":{"direct":true},"balance_after":58831,"source":{"system":"sec-edgar","filing":"0001209191-17-059710","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919117059710/doc4.xml","form_type":"4"}},{"id":4269069,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2017-06-30T20:50:19.000Z","date":"2017-06-29","kind":"exercise","acquired":false,"shares":9933,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":30.03,"expiration_date":"2018-10-31","underlying":"Common Stock","underlying_shares":9933},"source":{"system":"sec-edgar","filing":"0001209191-17-042554","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919117042554/doc4.xml","form_type":"4"}},{"id":4269068,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-30T20:50:19.000Z","date":"2017-06-28","kind":"exercise","acquired":false,"shares":56199,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested and exercisable."}],"balance_after":9933,"derivative":{"exercise_price":30.03,"expiration_date":"2018-10-31","underlying":"Common Stock","underlying_shares":56199},"source":{"system":"sec-edgar","filing":"0001209191-17-042554","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919117042554/doc4.xml","form_type":"4"}},{"id":4269067,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-30T20:50:19.000Z","date":"2017-06-29","kind":"sale","acquired":false,"shares":9933,"price":55.049,"value":546801.717,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exercise and sale were made pursuant to a 10b5-1 plan adopted by the reporting person on June 1, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price represents the approximate weighted average price per Share of the Issuer that were executed at prices ranging from $55.00 to $55.30 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price."}],"balance_after":8831,"source":{"system":"sec-edgar","filing":"0001209191-17-042554","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919117042554/doc4.xml","form_type":"4"}},{"id":4269066,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-30T20:50:19.000Z","date":"2017-06-29","kind":"exercise","acquired":true,"shares":9933,"price":30.0295,"value":298283.0235,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exercise and sale were made pursuant to a 10b5-1 plan adopted by the reporting person on June 1, 2016."}],"balance_after":18764,"source":{"system":"sec-edgar","filing":"0001209191-17-042554","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919117042554/doc4.xml","form_type":"4"}},{"id":4269065,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-30T20:50:19.000Z","date":"2017-06-28","kind":"sale","acquired":false,"shares":56199,"price":55.002,"value":3091057.398,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exercise and sale were made pursuant to a 10b5-1 plan adopted by the reporting person on June 1, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the approximate weighted average price per share of common stock (each, a \"Share\") of Xylem Inc. (the \"Issuer\"), of sales that were executed at prices ranging from $55.00 to $55.02 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price."}],"balance_after":8831,"source":{"system":"sec-edgar","filing":"0001209191-17-042554","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919117042554/doc4.xml","form_type":"4"}},{"id":4269064,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-30T20:50:19.000Z","date":"2017-06-28","kind":"exercise","acquired":true,"shares":56199,"price":30.0295,"value":1687627.8705,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exercise and sale were made pursuant to a 10b5-1 plan adopted by the reporting person on June 1, 2016."}],"balance_after":65030,"source":{"system":"sec-edgar","filing":"0001209191-17-042554","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919117042554/doc4.xml","form_type":"4"}},{"id":4321445,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-05-15T21:23:00.000Z","date":"2017-05-12","kind":"grant","acquired":true,"shares":588,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This restricted stock was granted on May 12, 2017 under the Edwards Lifesciences Corporation Nonemployee Directors Stock Incentive Program and is scheduled to become 100% vested after the earlier of one year from the grant date or Issuer's next annual meeting of stockholders."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person."}],"balance_after":4563,"source":{"system":"sec-edgar","filing":"0001225208-17-009787","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817009787/doc4.xml","form_type":"4"}},{"id":4321444,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-05-15T21:23:00.000Z","date":"2017-05-12","kind":"grant","acquired":true,"shares":2034,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 12, 2017 under the Edwards Lifesciences Corporation Nonemployee Directors Stock Incentive Program.  They are scheduled to become vested 100% after the earlier of one year from the grant date or Issuer's next annual meeting of stockholders. The underlying common stock (net of any shares sold to cover applicable taxes) must be held until the reporting person ceases to serve on Issuer's Board."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person."}],"balance_after":3975,"source":{"system":"sec-edgar","filing":"0001225208-17-009787","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817009787/doc4.xml","form_type":"4"}},{"id":4324460,"issuer":{"id":430,"kind":"organization","name":"Xylem Inc.","symbol":"XYL"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-11T23:50:49.000Z","date":"2017-05-10","kind":"grant","acquired":true,"shares":2743,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2018 annual shareholder's\nmeeting."}],"balance_after":8831,"source":{"system":"sec-edgar","filing":"0001209191-17-031669","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226924/000120919117031669/doc4.xml","form_type":"4"}}]}